Status:
COMPLETED
Air Optix® Night and Day® Aqua Daily Wear
Lead Sponsor:
Alcon Research
Conditions:
Refractive Errors
Myopia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix® Night and Day® Aqua (AONDA) contact lenses in a real-world setting when worn...
Detailed Description
This is a non-interventional/observational study designed as a retrospective chart review. Study sites will review charts within their existing database to identify subjects who wore AONDA contact len...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Normal eyes, as determined by the Investigator
- At the time of the 1-year visit, subject was prescribed and wearing AONDA contact lenses or PV2 contact lenses in both eyes in a daily wear modality for at least approximately 1 year without changing wear modality
- Baseline and 1-year visit charts available
- Other protocol-specified inclusion criteria may apply
- Exclusion Criteria
- Any recurrent history or active anterior segment infection, inflammation, abnormality, or disease contraindicating regular contact lens wear present at Baseline
- Use of systemic or ocular medications contraindicating regular contact lens wear at Baseline
- History of refractive surgery or irregular cornea
- Other protocol-specified exclusion criteria may apply
Exclusion
Key Trial Info
Start Date :
October 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2024
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT05976750
Start Date
October 3 2023
End Date
July 30 2024
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, United States, 76134